Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Infectious Disease Modelling , 2022 (15)
October, 2022 (3)
- A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makers.
Thompson J, McClure R, Scott N, Hellard M, Abeysuriya R, Vidanaarachchi R, Thwaites J, Lazarus JV, Lavis J, Michie S, Bullen C, Prokopenko M, Chang SL, Cliff OM, Zachreson C, Blakely A, Wilson T, Ouakrim DA, Sundararajan V
Health Res Policy Syst. 2022 Oct; 20(1):107 - Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
Sanz-Leon P, Hamilton LHW, Raison SJ, Pan AJX, Stevenson NJ, Stuart RM, Abeysuriya RG, Kerr CC, Lambert SB, Roberts JA
Philos Trans A Math Phys Eng Sci. 2022 Oct; 380(2233):20210311 - Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan.
Houdroge F, Yunus H, Delport D, Stearns E, Palmer A, Naim A, Kashif A, Pyne HH, Scott N, Oelrichs R, Wilson D
BMJ Glob Health. 2022 Oct; 7(10)
September, 2022 (1)
- Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
Bershteyn A, Jamieson L, Kim HY, Platais I, Milali MP, Mudimu E, Ten Brink D, Martin-Hughes R, Kelly SL, Phillips AN, Bansi-Matharu L, Cambiano V, Revill P, Meyer-Rath G, Nichols BE
Lancet Glob Health. 2022 Sep; 10(9):e1298-e1306
June, 2022 (1)
- The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia.
Saul A, Scott N, Spelman T, Crabb BS, Hellard M
BMC Infect Dis. 2022 Jun; 22(1):514
May, 2022 (5)
- Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
Ten Brink DC, Martin-Hughes R, Minnery ME, Osborne AJ, Schmidt HA, Dalal S, Green KE, Ramaurtarsing R, Wilson DP, Kelly SL
PLoS One. 2022 May; 17(5):e0268240 - Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study.
Seaman CP, Mvundura M, Frivold C, Morgan C, Jarrahian C, Howell J, Hellard M, Scott N
PLoS Glob Pub Health. 2022 May; 2(5):e0000394 - A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Szanyi J, Wilson T, Scott N, Blakely T
Vaccine. 2022 May; 40(28):3821-3824 - Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V; HIV Modelling Consortium.
Lancet HIV. 2022 May; 9(5):e353-e362 - Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, Vanuatu.
van Gemert C, Tarivonda L, Tapo PS, Natuman S, Clark G, Mariasua J, Scott N, Craig A, Abel M, Cornish MJ, Hellard M, Sacks-Davis R
Emerg Infect Dis. 2022 May; 28(5):1053-1055
April, 2022 (1)
- Mathematical modelling of the mosquito Aedes polynesiensis in a heterogeneous environment.
Heath K, Bonsall MB, Marie J, Bossin HC
Math Biosci. 2022 Apr; 348:108811
March, 2022 (3)
- Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses.
Martin-Hughes R, Vu L, Cheikh N, Kelly SL, Fraser-Hurt N, Shubber Z, Manhic I, Mbendera K, Girma B, Pambudi I, Rıos J, Elmira A, Harimurti P, Hafez R, Nicolas Bayona Garcia J, Palmer T, Roberts A, Gorgens M, Wilson D
PLoS Glob Pub Health. 2022 Mar; 2(3):e0000219 - Preventing a cluster from becoming a new wave in settings with zero community COVID-19 cases.
Abeysuriya RG, Delport D, Stuart RM, Sacks-Davis R, Kerr CC, Mistry D, Klein DJ, Hellard M, Scott N
BMC Infect Dis. 2022 Mar; 22(1):232 - Quantification of the dynamics of antibody response to malaria to inform sero-surveillance in pregnant women.
Dharmaratne ADVTT, Dini S, O'Flaherty K, Price DJ, Beeson J, McGready R, Nosten F, Fowkes FJI, Simpson JA, Zaloumis SG
Malar J. 2022 Mar; 21(1):75
January, 2022 (1)
- Assessment of the cost-effectiveness of Australia’s risksharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study.
Scott N, Palmer A, Tidhar T, Stoové M, Sacks-Davis R, Doyle JS, Pedrana A, Thompson AJ, Wilson DP, Hellard M
Lancet Reg Health - West Pac. 2022 Jan; 18:100316
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (2)
- Towards Eliminating HIV (20)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (264)
- Maternal, Child and Adolescent Health (200)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (104)
- Eliminate Malaria (42)
- Eliminate Tuberculosis (TB) (14)
- Finance (0)
- Healthy Ageing (1)
- Human Resources (0)
- Burnet Honorary Research Fellows (8)
- Research Support and Facilities (0)
- Harm Reduction (8)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (37)
- Education & Training (0)
- Infectious Diseases Elimination (2)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (1)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (27)
- Sexually Transmitted Infections (STIs) (8)
- Maternal and Child Health (60)
- Malaria (47)
- Immune Disease and Cancer (4)
- Hepatitis B (17)
- Hepatitis C (30)
- Global infectious disease threats (7)
- Injecting Drug Use (36)
- Alcohol and Other Drugs (38)
- Tuberculosis (TB) (14)
- Young People's Health (9)
- Justice Health (11)
- Nutrition (3)
- Sexual and Reproductive Health (12)
- Infectious Disease Modelling (15)
- Infectious Diseases Surveillance (2)
- LGBTQIA+ (6)
- Influenza (1)
- Global Adolescent Health (9)
- COVID-19 (novel coronavirus) (50)
